Related Experiment Video
Updated: Mar 3, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC
Xiao-Yan Wang1,2, Sheng-Nan Li1,2, Hui-Fang Zhu1,2
1Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Abstract:
Response gene to complement 32 (RGC32) is a transcription factor that regulates the expression of multiple genes involved in cell growth, viability and tissue-specific differentiation. However, the role of RGC32 in tumorigenesis and tumor progression in colorectal cancer (CRC) has not been fully elucidated. Here, we showed that the expression of RGC32 was significantly up-regulated in human CRC tissues versus adjacent normal tissues. RGC32 expression was significantly correlated with invasive and aggressive characteristics of tumor cells, as well as poor survival of CRC patients. We also demonstrated that RGC32 overexpression promoted proliferation, migration and tumorigenic growth of human CRC cells in vitro and in vivo. Functionally, RGC32 facilitated epithelial-mesenchymal transition (EMT) in CRC via the Smad/Sip1 signaling pathway, as shown by decreasing E-cadherin expression and increasing vimentin expression. In conclusion, our findings suggested that overexpression of RGC32 facilitates EMT of CRC cells by activating Smad/Sip1 signaling.
Insights
Response gene to complement 32 (RGC32) is upregulated in colorectal cancer (CRC), promoting tumor growth and spread. RGC32 facilitates epithelial-mesenchymal transition (EMT) in CRC via the Smad/Sip1 pathway, indicating its role in cancer progression.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Response gene to complement 32 (RGC32) is a transcription factor regulating cell growth, viability, and differentiation.
- The role of RGC32 in colorectal cancer (CRC) tumorigenesis and progression requires further investigation.
Purpose of the Study:
- To elucidate the role of RGC32 in the development and progression of colorectal cancer.
- To investigate the correlation between RGC32 expression and clinicopathological features and patient survival in CRC.
Main Methods:
- Analysis of RGC32 expression in human CRC tissues and adjacent normal tissues.
- In vitro and in vivo studies to assess the effects of RGC32 overexpression on CRC cell proliferation, migration, and tumorigenic growth.
- Investigation of the underlying molecular mechanisms, including the Smad/Sip1 signaling pathway and epithelial-mesenchymal transition (EMT) markers.
Main Results:
- RGC32 expression was significantly upregulated in CRC tissues compared to normal tissues.
- RGC32 expression correlated with invasive and aggressive tumor characteristics and predicted poor patient survival.
- RGC32 overexpression enhanced CRC cell proliferation, migration, and in vivo tumor growth.
- RGC32 facilitated EMT in CRC by decreasing E-cadherin and increasing vimentin expression via the Smad/Sip1 pathway.
Conclusions:
- Overexpression of RGC32 is a significant factor in colorectal cancer progression.
- RGC32 promotes CRC tumorigenesis and metastasis by facilitating epithelial-mesenchymal transition (EMT).
- Targeting RGC32 or the Smad/Sip1 pathway may offer therapeutic strategies for CRC.
Related Concept Videos
The Ras Gene
Ras is a...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
TGF - β Signaling Pathway
MAPK Signaling Cascades

